Optimal fluid control can normalize cardiovascular risk markers and limit left ventricular hypertrophy in thrice

Nestor Velasco1, Paul Chamney, Peter Wabel

  • 1John Stevenson Lynch Renal Unit, NHS Ayrshire & Arran, Kilmarnock, UK.

Hemodialysis International. International Symposium on Home Hemodialysis
|April 21, 2012
PubMed

Insights

Maintaining normal fluid levels in thrice-weekly hemodiafiltration patients is key. Time-averaged fluid overload (TAFO) and cardiac biomarkers can be normal, suggesting bioimpedance monitoring as a practical alternative.

Area of Science:

  • Nephrology
  • Cardiology
  • Biomedical Engineering

Background:

  • Chronic fluid overload in hemodialysis patients is linked to left ventricular hypertrophy and elevated cardiac biomarkers, increasing mortality risk.
  • While increased dialysis frequency aids fluid management, many patients remain on thrice-weekly treatments.
  • Left ventricular hypertrophy (LVH) is a significant concern in chronic kidney disease patients undergoing hemodialysis.

Purpose of the Study:

  • To investigate the relationship between time-averaged fluid overload (TAFO), cardiac biomarkers (cTnT, NT-proBNP), and left ventricular mass index (LVMI) in thrice-weekly hemodiafiltration patients.
  • To assess if normally hydrated patients on thrice-weekly hemodiafiltration have cardiac biomarker and TAFO levels comparable to the general population.
  • To explore bioimpedance spectroscopy as a practical alternative to serum cardiac biomarkers for monitoring fluid status.

Main Methods:

  • Studied 30 patients undergoing thrice-weekly hemodiafiltration.
  • Measured serum cardiac troponin T (cTnT), N-terminal prohormone brain natriuretic peptide (NT-proBNP), left ventricular mass index (LVMI) via cardiac MRI, and ambulatory blood pressure.
  • Quantified time-averaged fluid overload (TAFO) using bioimpedance spectroscopy.

Main Results:

  • Twenty-six percent of patients exhibited left ventricular hypertrophy.
  • Lower LVMI was significantly associated with TAFO <1 L, NT-proBNP <1200 pg/mL, or cTnT <0.1 ug/L (P < 0.05).
  • A significant number of patients achieved normal levels for TAFO, cTnT, and NT-proBNP, suggesting normal hydration is achievable and associated with better cardiac parameters.

Conclusions:

  • Normally hydrated thrice-weekly hemodiafiltration patients can exhibit cardiac biomarker and TAFO levels similar to healthy individuals.
  • Bioimpedance monitoring of TAFO offers a practical and potentially valuable alternative to traditional serum cardiac biomarkers for assessing fluid status and cardiac risk.
  • Effective fluid management is crucial for mitigating cardiac complications in hemodialysis patients.

Related Concept Videos

Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...